Phase I Safety and Immunogenicity Evaluations of an Alphavirus Replicon HIV-1 Subtype C gag Vaccine in Healthy HIV-1-Uninfected Adults

On the basis of positive preclinical data, we evaluated the safety and immunogenicity of an alphavirus replicon HIV-1 subtype C gag vaccine (AVX101), expressing a nonmyristoylated form of Gag, in two double-blind, randomized, placebo-controlled clinical trials in healthy HIV-1-uninfected adults. Esc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wecker, M., Gilbert, P., Russell, N., Hural, J., Allen, M., Pensiero, M., Chulay, J., Chiu, Ya-Lin, Abdool Karim, S. S., Burke, D. S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2012
Assuntos:
Vaccines
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3485893/
https://ncbi.nlm.nih.gov/pubmed/22914365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00258-12
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados